Xopenex - 63402-513-24 - (levalbuterol hydrochloride)

Alphabetical Index


Drug Information of Xopenex

Product NDC: 63402-513
Proprietary Name: Xopenex
Non Proprietary Name: levalbuterol hydrochloride
Active Ingredient(s): 1.25    mg/3mL & nbsp;   levalbuterol hydrochloride
Administration Route(s): RESPIRATORY (INHALATION)
Dosage Form(s): SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Xopenex

Product NDC: 63402-513
Labeler Name: Sunovion Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020837
Marketing Category: NDA
Start Marketing Date: 19990401

Package Information of Xopenex

Package NDC: 63402-513-24
Package Description: 2 POUCH in 1 CARTON (63402-513-24) > 12 VIAL, SINGLE-DOSE in 1 POUCH (63402-513-00) > 3 mL in 1 VIAL, SINGLE-DOSE

NDC Information of Xopenex

NDC Code 63402-513-24
Proprietary Name Xopenex
Package Description 2 POUCH in 1 CARTON (63402-513-24) > 12 VIAL, SINGLE-DOSE in 1 POUCH (63402-513-00) > 3 mL in 1 VIAL, SINGLE-DOSE
Product NDC 63402-513
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name levalbuterol hydrochloride
Dosage Form Name SOLUTION
Route Name RESPIRATORY (INHALATION)
Start Marketing Date 19990401
Marketing Category Name NDA
Labeler Name Sunovion Pharmaceuticals Inc.
Substance Name LEVALBUTEROL HYDROCHLORIDE
Strength Number 1.25
Strength Unit mg/3mL
Pharmaceutical Classes Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]

Complete Information of Xopenex


General Information